Daejeon, South Korea

Jong-Chan Son


Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1998-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jong-Chan Son: Innovator in Antiviral Research

Introduction: Jong-Chan Son, a prominent inventor based in Daejeon, South Korea, has made significant contributions to the field of antiviral research. With a total of three patents, his innovative work focuses on developing compounds that exhibit high antiviral activity, specifically targeting HIV-1 and its mutant strains.

Latest Patents: One of Jong-Chan Son's latest patents is titled "Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof." This patent details the formulation of 2,4-pyrimidinedione derivatives, which have shown high antiviral efficacy against both wild-type and mutant strains of HIV-1. These derivatives possess low toxicity and represent a promising avenue for treating AIDS. The compounds are characterized by their complex molecular structures, incorporating various substituents that enhance their therapeutic potential.

Career Highlights: Throughout his career, Jong-Chan Son has been affiliated with esteemed institutions, including the Korea Research Institute of Chemical Technology. His work has not only contributed to hisown success but has also advanced the field of medicinal chemistry, particularly in the realm of antiviral drug development.

Collaborations: Jong-Chan Son has collaborated with notable colleagues, such as III-Young Lee and Byung-II Bae, enhancing the scope and impact of his research. These collaborations have helped foster a creative and innovative environment, facilitating the exploration of new ideas and strategies in antiviral therapeutics.

Conclusion: Jong-Chan Son's dedication to innovation in antiviral research underscores the vital role of inventors in addressing global health challenges. His contributions through patents not only reflect his expertise but also hold the potential for transformative impacts in the treatment of viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…